RECENT PROGRESS IN THE ELUCIDATION OF THE MECHANISM OF ACTION OF ERGOT COMPOUNDS USED IN MIGRAINE THERAPY 1
- 1 September 1972
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 2 (S2) , 15-26
- https://doi.org/10.5694/j.1326-5377.1972.tb93041.x
Abstract
Ergot alkaloids are the main standby in the treatment and prophylaxis of the migraine attack. Without exception, the ergot alkaloids and derivatives employed in this indication were discovered and developed by Sandoz. Not surprisingly, therefore, the action mechanism of these substances is constantly under investigation in our research laboratories. The results I am presenting are the fruit of our last few years' work. I was not directly involved in these researches, but I shall mention my colleagues by name in connection with each aspect discussed. I shall first deal with vascular effects of various ergot alkaloids, and shall go on to discuss the influence of ergot compounds on storage and release of biogenic amines. Lastly, I shall say a few words about a new compound chemically different from the regot alkaloids which shows similar actions in some animal models and has proved to be efficacious in prophylaxis of the migraine attack.Keywords
This publication has 9 references indexed in Scilit:
- The effects of Hydergine on acutely denervated cat skeletal muscle vasculatureNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1972
- Effects of methysergide on platelets incubated with reserpineBritish Journal of Pharmacology, 1971
- Effects of ergotamine and dihydroergotamine on uptake of 5-hydroxytryptamine in blood plateletsEuropean Journal of Pharmacology, 1970
- Comparative Effects of Dihydroergotamine and Noradrenaline on Resistance, Exchange and Capacitance Functions in the Peripheral CirculationClinical Science, 1970
- Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bedBritish Journal of Pharmacology, 1969
- The effect of ergotamine on humoral and neuronal actions in the nictitating membrane and the spleen of the catNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1968
- Dual site of action of phenoxybenzamine in the cat's spleen: Blockade of α-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrineCellular and Molecular Life Sciences, 1964